Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion

Circulation Research
K A PritchardM B Stemerman

Abstract

To examine mechanisms by which native low-density lipoprotein (n-LDL) perturbs endothelial cell (EC) release of superoxide anion (O2-) and nitric oxide (NO), ECs were incubated with n-LDL at 240 mg cholesterol per deciliter for 4 days with media changes every 24 hours. n-LDL increases EC release of O2- by more than fourfold and increases nitrite production by 57%. In the conditioned media from day-4 incubations, n-LDL increases total nitrogen oxides 20 times control EC (C-EC) levels. However, n-LDL did not alter EC NO synthase (eNOS) enzyme activity as measured by the [3H]citrulline assay. N omega-Nitro-L-arginine methyl ester, a specific inhibitor of eNOS activity, increases C-EC release of O2- by > 300% but decreases LDL-treated EC (LDL-EC) release by > 95%. L-Arginine inhibits the release of O2- from LDL-ECs by > 95% but did not effect C-EC release of O2-. Indomethacin and SKF 525A partially attenuate LDL-induced increases in O2- production by approximately 50% and 30%, respectively. Thus, n-LDL increases O2- and NO production, which increases the likelihood of the formation of peroxynitrite (ONOO-), a potent oxidant. n-LDL increases the levels of nitrotyrosine, a stable oxidation product of ONOO-, and tyrosine by approximat...Continue Reading

References

Oct 1, 1992·The Tohoku Journal of Experimental Medicine·T Curran
Nov 1, 1992·Archives of Biochemistry and Biophysics·H IschiropoulosJ S Beckman
Nov 1, 1992·Chemical Research in Toxicology·W H KoppenolJ S Beckman
Jun 18, 1991·European Journal of Pharmacology·D SalveminiJ Vane
Jan 11, 1991·The American Journal of Physiology·K A PritchardM B Stemerman
Apr 1, 1990·Journal of Cellular Physiology·J A HollandM B Stemerman
Dec 1, 1990·The Journal of Clinical Investigation·R L MinorD G Harrison
Jun 1, 1987·The Journal of Clinical Investigation·T D EngersonH P Jones
Jan 1, 1987·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·M E RosenfeldR Ross
Dec 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G M Rosen, B A Freeman
Jan 1, 1984·Annual Review of Pharmacology and Toxicology·R F Furchgott
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·O G KhatsenkoJ R Vane
May 1, 1994·The Journal of Clinical Investigation·D SalveminiP Needleman
Jan 6, 1995·The Journal of Biological Chemistry·J K LiaoS L Clark
Jan 1, 1995·Annual Review of Physiology·O W Griffith, D J Stuehr
Aug 1, 1993·The American Journal of Physiology·P J PaganoR A Cohen
Feb 1, 1994·Free Radical Biology & Medicine·N W KooyJ S Beckman
May 1, 1994·Archives of Biochemistry and Biophysics·N W Kooy, J A Royall
Feb 1, 1994·Biological Chemistry Hoppe-Seyler·J S BeckmannC R White
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·C R WhiteB A Freeman
Jun 1, 1993·The Journal of Clinical Investigation·Y OharaD G Harrison
May 1, 1993·Biochemical Society Transactions·J S Beckman, J P Crow

❮ Previous
Next ❯

Citations

Feb 24, 2000·The Journal of Pathology·H Li, U Förstermann
Jul 6, 2000·Journal of Physiology and Biochemistry·G ZalbaJ Díez
Jul 5, 2008·Basic Research in Cardiology·Cuihua Zhang
Mar 23, 2010·Pflügers Archiv : European journal of physiology·Ulrich Förstermann
Dec 19, 2007·Pharmaceutical Research·R Preston MasonTadeusz Malinski
Apr 5, 2001·Current Atherosclerosis Reports·J P Cooke, R K Oka
Jun 12, 2004·Current Atherosclerosis Reports·Louis J Ignarro, Claudio Napoli
Jan 25, 2005·Current Diabetes Reports·Louis J Ignarro, Claudio Napoli
Feb 15, 2001·Current Hypertension Reports·A WarnholtzT Münzel
May 2, 2003·Current Hypertension Reports·Stefan John, Roland E Schmieder
Sep 12, 2000·Current Hypertension Reports·R Busse, I Fleming
Jan 1, 1996·Free Radical Biology & Medicine·J A Berliner, J W Heinecke
Dec 4, 2003·Free Radical Biology & Medicine·Yunpeng DuT S Kern
Apr 24, 2013·Trends in Pharmacological Sciences·Huige LiUlrich Förstermann
Nov 18, 2000·The American Journal of Cardiology·D D Waters, R R Azar
Nov 6, 2001·The American Journal of Cardiology·D D Waters
Dec 20, 1996·Atherosclerosis·J H LinM B Stemerman
Feb 9, 2000·Pharmacology & Therapeutics·A T Demiryürek, R M Wadsworth
Mar 14, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·V R Muzykantov
Jul 18, 2000·Journal of the American College of Cardiology·P A KaufmannP G Camici
Dec 29, 2000·Journal of the American College of Cardiology·R H BögerJ P Cooke
Jul 24, 2003·Journal of the American College of Cardiology·Ken-ichiro SasakiTsutomu Imaizumi
Feb 6, 1999·Journal of the American College of Cardiology·W H KaesemeyerR W Caldwell
Feb 11, 1999·Journal of the American College of Cardiology·T HeitzerH Drexler
Aug 18, 2000·Free Radical Biology & Medicine·R P PatelV M Darley-Usmar
Oct 12, 2001·Free Radical Biology & Medicine·J Vásquez-VivarB Kalyanaraman
Jul 11, 2003·Free Radical Biology & Medicine·Kai ChenJohn F Keaney
May 20, 1998·Free Radical Biology & Medicine·L G RochelleK B Adler
Oct 17, 2002·Nitric Oxide : Biology and Chemistry·Huige LiUlrich Förstermann
Dec 1, 1996·Molecular Medicine Today·H Bult
Dec 11, 2003·Atherosclerosis. Supplements·Karsten Sydow, Thomas Münzel
Dec 11, 2003·Atherosclerosis. Supplements·John P Cooke
Apr 23, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Eberhard SchulzThomas Münzel
May 12, 2000·British Journal of Pharmacology·G Abou-MohamedR W Caldwell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.